Bisphosphonates and cancer

Bisphosphonates are drugs that can help to strengthen bones and reduce the risk of bones breaking. You might have bisphosphonates to:

• help to prevent or slow down bone thinning (osteoporosis)

• treat a high level of calcium in the blood (hypercalcaemia)

• reduce pain from cancer that has spread to the bone

• treat some types of cancer that cause bone damage

You have bisphosphonates either as tablets or as a drip (infusion) into a vein in your arm.

Another drug called denosumab is a bone targeted treatment. It’s a type of targeted therapy called a monoclonal antibody.

Go to information about denosumab

Cancers that can affect bones

Most cancers that affect bones are ones that have started in another part of the body and have spread to the bone. This is called secondary bone cancer. The most common types of cancer that spread to the bone are breast, prostate and lung cancer.

Myeloma develops from cells in the bone marrow called plasma cells. Bone marrow is the spongy tissue found inside the inner part of some of our large bones.

Some types of cancer treatment can also affect the bones making them weaker.

How do bisphosphonates work?

To understand how bisphosphonates work, it helps to know a bit about normal bone activity.

Normal bone activity 

Your bones are made of living tissue, and are constantly changing. In healthy bones, specialised bone cells constantly break down and replace bone tissue.

These specialised bone cells are:

• osteoclasts, these cells break down old bone

• osteoblasts which build new bone

This process is called bone remodelling. There is a very good balance between the rates of bone breakdown and growth, which keeps bones strong and healthy.

Bisphosphonates are drugs that target areas of higher bone turnover. The osteoclast cells, which break down old bone, absorb the bisphosphonate drug. Their activity is slowed down. This reduces bone breakdown.

There are several different types of bisphosphonates, and they each work slightly differently. Doctors are still learning more about the exact ways in which bisphosphonates work. 

We know that bisphosphonates can:

• interfere with the formation of osteoclasts

• make osteoclasts self destruct or die early

• change the signalling between osteoclasts and osteoblasts

• form a barrier between the bone and the osteoclast

Researchers have found that some types of bone targeted treatments can:

• prevent or slow down the activity of bone disease and improve symptoms in people with myeloma

• prevent or reduce bone problems, including for pain relief, in some people with advanced prostate cancer

• help reduce the rate of early breast cancer coming back in the bone for some postmenopausal women

• help some postmenopausal women with early breast cancer live longer

• help to prevent complications from other cancers that have spread to the bones

Cancer cells seem to be attracted to an environment where bones are being broken down. Researchers hope that stopping this process could slow cancer growth and help people live longer, as well as reduce bone damage.